glutathione and triple negative breast cancer Role of in Cancer: From Mechanisms to Therapies Frontiers | Ferroptosis: the emerging
Frontiers Ferroptosis: the emerging player in remodeling triple negative breast cancer Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis augment to surmount triple negative breast cancer ScienceDirect A review of biological targets and therapeutic approaches in the management of triple negative breast cancer ScienceDirect GSTP1 Is a Driver of Triple Negative Breast Cancer Cell Metabolism and Pathogenicity ScienceDirect
Pay in 4 interest-free payments of $6.89 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26



